Sign In
Buy PGPHF
$890.00
-7.00 (-0.780%)
At Close: Jun 04, 2026
Report: Walgreens Discusses Sale to Private Equity Firm Sycamore Partners
04:58pm, Tuesday, 10'th Dec 2024
Walgreens Boots Alliance and Sycamore Partners are reportedly discussing a deal that would see Walgreens sold to the private equity firm. A deal could be completed early next year, although the talks
Artisan Partners Asset Management Inc. Reports November 2024 Assets Under Management
04:16pm, Tuesday, 10'th Dec 2024
MILWAUKEE, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management ("AUM") as of November 30, 2024 totaled $1
Walgreens shares soar 21% on reported talks to sell itself to Sycamore Partners
01:07pm, Tuesday, 10'th Dec 2024
Sycamore would likely sell off pieces of the business or work with partners, according to the report.
Walgreens Is in Talks to Sell Itself to Private-Equity Firm Sycamore Partners
12:31pm, Tuesday, 10'th Dec 2024
Deal would cap tumultuous run for retailer whose market value shrank from a peak of over $100 billion to below $8 billion.
The global collaborative robot market is set for explosive growth, with projections indicating a surge to $14.67 Billion by 2031. This remarkable expansion, driven by growing adoption of collaborative
Acquisition by Energy Capital Partners and Co-Investors Approved by the High Court of Justice of England and Wales
08:37am, Tuesday, 10'th Dec 2024
Acquisition by Energy Capital Partners and Co-Investors Approved by the High Court of Justice of England and Wales December 10, 2024 – Atlantica Sustainable Infrastructure plc (NASDAQ: AY) (“Atlan
Presentation Details Why MRMC's Proposed Merger Significantly Undervalues MMLP, the Deeply Flawed Valuation Methodologies and Financial Analysis Used to Justify the Inadequate Merger Consideration, an
Early Results and Upsizing of EQM Midstream Partners, LP's Tender Offer and Consent Solicitation for Certain of its Senior Notes
06:30am, Tuesday, 10'th Dec 2024
PITTSBURGH , Dec. 10, 2024 /PRNewswire/ -- EQT Corporation (NYSE: EQT) ("EQT" and, collectively with its subsidiaries, the "Company") today announced the early results and upsizing of the previously a
Monroe Capital Supports Sumeru Equity Partners' Acquisition of JobNimbus
06:00am, Tuesday, 10'th Dec 2024
CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC (“Monroe”) announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of J
NextEra Energy Partners: Fire-Sale Discount As Clean Energy Proves Resilience
10:56pm, Monday, 09'th Dec 2024
The clean energy sector has struggled post-election, with solar and wind ETFs down significantly, influenced by potential policy changes and higher interest rates. NextEra Energy Partners has drastica
KNOT Offshore Partners: No Visible Near-Term Catalysts - Hold
10:13pm, Monday, 09'th Dec 2024
Leading shuttle tanker operator KNOT Offshore Partners reported mixed Q3/2024 with the company's bottom line impacted by derivative losses and inflationary pressures on operating expenses. A recent ve
Stellantis Partners With Zeta Energy to Develop Advanced EV Batteries
12:05pm, Monday, 09'th Dec 2024
STLA signs a contract with Zeta Energy to develop lithium-sulfur EV batteries with breakthrough gravimetric energy density.
Lamps Plus Partners with Manhattan to Improve Demand Forecasting, Inventory Accuracy
11:52am, Monday, 09'th Dec 2024
ATLANTA--(BUSINESS WIRE)--Manhattan Associates has announced that Lamps Plus, the nation's leading specialty lighting retailer, has implemented Manhattan's DFIO solution.
NewLake Capital Partners: Hold Out For This Cannabis-Driven REIT With Immense Potential
10:50am, Monday, 09'th Dec 2024
NewLake Capital Partners (NLCP) is a promising cannabis-focused REIT with strong financials, high dividend yields and no debt. Comps show that NLCP stands out in profitability and dividends too. NLCP
MP0533 phase 1/2a dose escalation study continues with overall acceptable safety profile to date as well as initial antileukemic and pharmacodynamic activity
